The effects of smoking on the development of work related asthma and on the production of specific IgE and IgG antibodies to antigen from a contaminated humidifier are described for a sample of 258 workers from a printing factory. Current smoking was associated with low production of IgG antibody but with higher production of IgE antibody. No dose response for either antibody was found when numbers of cigarettes or pack-years smoked were considered. Work related asthma was detected in 12 workers by peak flow recordings. Six were current smokers and one was an ex-smoker. One subject with work related asthma had a high (and one a marginal) concentration of specific IgE to humidifier antigen. 
specific IgG antibody.56 One previous study has examined the effect of tobacco smoking on both specific IgE and IgG antibody responses. This study of a workforce preparing prawns found that the prevalence ofspecific IgE was greater and that of IgG was less among current smokers than among nonsmokers. 3 We have examined IgE and IgG responses to airborne antigen in a factory population exposed to contaminated humidifiers (the results of precipitin tests have already been reported for this population). 5 We have examined the relation of these responses to smoking habits and the IgE response to the development of work related asthma.
Subjects and methods
The study population was the workforce ofa printing factory that was supplied with humidified air by two large water spray humidifiers. At the time of the study these had been operational for 19 years. Both the sump tanks and the eliminator plates were heavily contaminated by a dark brown jelly-like slime. The workforce was investigated to determine the cause of an outbreak of asthma. During the investigation the employees answered a modified Medical Research Council questionnaire administered by an interviewer. This included questions about occupational history, history of smoking, and the relation of respiratory symptoms (wheezing, shortness of breath, and chest tightness) to periods at work. Serum samples were obtained from all who consented.
Subjects were categorised on the basis of answers to the questionnaire into current smokers if they smoked one or more cigarettes a day, never smokers if they had never smoked or smoked less than one cigarette a day, and ex-smokers if they had stopped smoking for at least six months. Ex-smokers were included with never smokers in a group called nonsmokers. Ex-smokers were asked the year in which they stopped smoking. 
Results

POPULATION
Of the 258 workers interviewed, 203 gave a blood sample. All of these were tested for precipitating and specific antibodies to HAA. Later, during a move to a different laboratory, some sera were mislaid and only 126 were available for specific IgE measurements. These included 11 of the 12 workers with work related asthma. In the 203 sera a strong negative correlation was found between strength of precipitin reaction to HAA and intensity of current smoking, with never smokers having strongly positive precipitins; the values of ex-smokers were intermediate.5 SKIN 
PRICK TESTS
One hundred and three subjects volunteered for skin testing. Thirty three of these were atopic; 10 gave positive reactions to HAA and seven of these were atopic. Figure 1 shows the distribution of specific IgE concentrations for the current, ex-, and never smokers. With either method of establishing a normal range for specific IgE, only two values among the never smokers (n = 45) were above this range and both were less than 2% binding (mean 1-35%). For the ex-smokers (n = 29), four values were above 0 71% binding (mean 1 9%) and three values were above 1-0% (mean 2 25). For the current smokers (n = 52) nine values were above 0-71% binding (mean 6 5%) and eight values above 1 0% (mean 7 2). The relative risk of developing raised specific IgE to HAA The results of self' recorded peak flow measurements were consistent with work related asthma in 12 workers. Of these, two had evidence of specific IgE antibody to humidifier antigens (both were current smokers). Of the 12 with work related asthma six were current smokers and nine had positive precipitins to humidifier antigens.
Our data are consistent with the hypothesis that smoking exerts an enhancing effect on production of IgE and an inhibitory effect on production of IgG in adults exposed to novel antigens in the workplace. The effect of smoking on production of IgE seems to affect only a small percentage of the smoking population (as most have normal values of specific IgE), unlike its effect on production of IgG where smoking habit appears to be the dominant factor determining the concentration of IgG.
To test the theory that smoking exerts a permissive effect on production of IgE to novel antigen during the initial period of exposure, we compared the specific IgE concentrations in ex-smokers who had been exposed to HAA while still smoking with the specific IgE concentrations in ex-smokers who had not been exposed. Similarly, we compared the specific IgE concentrations in current smokers who were and current smokers who were not smoking at the start of their exposure. Although there were no statistically significant differences between the groups (ex-and current smokers) that had raised specific IgE concentrations and the groups that had not, the results are consistent with the theory that smoking at the onset of exposure may be one of the mechanisms involved in switching on production of IgE to a novel antigen.
The cause of the opposing effects of cigarette smoking on asthma and production of IgE and on allergic alveolitis or humidifier fever and production of IgG is not clear.'3 The effect on asthma seems localised; smoking increased production of IgE antibody to ovalbumen in rats when inhaled but not when injected subcutaneously.'4 Inhalation of cigarette smoke by guinea pigs caused mucosal inflammation and increased airway permeability to a marker protein, horseradish peroxidase."5 The permissive effect of cigarette smoking on production of IgE could be a consequence of increased permeability of the airway mucosa allowing antigen access to submucosal immunocompetent cells. The cause of the inhibitory effect ofsmoking on production of IgG and allergic alveolitis is even less clear but may be the consequence of reduced antigen penetration into the peripheral parts of the lungs of smokers or impaired presentation of antigen by alveolar macrophages; MHC2 expression and consequently the ability to present antigen is reduced in alveolar macrophages recovered from cigarette smokers by bronchoalveolar lavage. '6 Requests for reprints to: Dr Finnegan, Chest Clinic, Bamet General Hospital, Bamet, Herts EN5 3DJ.
